LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
After being convicted on all charges he faced, the former Theranos COO was sentenced to 12 years, 11 months on Dec. 7.
Co-owners sentenced to three years each for paying millions in kickbacks for referrals to their Brooklyn-based facilities.
While civil actions, criminal actions, and exclusions are up, the increased activity isn’t yet reflected in total recoveries.
A recent study led by a team at the University of Gothenburg shows that multiple biomarkers could ID the disease even in people with no symptoms.
Learn why this is the perfect time of the year to mobilize your board members.
Readers can now gain full access to our four briefings for up to seven days for free.
The company’s third attempt at shaking up the healthcare industry, Amazon Clinic, might just prove the charm.
Enforcement actions over our most recent coverage period were related to other areas of the healthcare industry.
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.
On Nov. 15, a psychiatrist and clinical lab owner pled guilty to his role in a complicated $3.8 million fraud scheme.